Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill to expand naloxone options in state portal
Summary
SB 542, which would require the state naloxone portal to offer all FDA‑approved opioid antagonists rather than a single‑dose product, was reported out of the House Health Policy Committee unanimously. Lawmakers cited real incidents where a single dose was insufficient.
The House Health Policy Committee reported SB 542, a bill sponsored in the Senate by Sen. Hertel, which would require the Department of Health and Human Services to offer all FDA‑approved opioid antagonists through the state naloxone portal rather than only a single‑dose product. The committee moved the bill with a unanimous recorded vote (18 yays, 0 nays).
Matt Black,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
